PDA

View Full Version : Davis Phinney Foundation Charity Ride and Dinner


admin
11-15-2004, 09:32 AM
Davis Phinney Foundation Charity Ride and Dinner
November 19th
Bicycle Ranch
Scottsdale, AZ

Bicycle Ranch is proud to announce the Davis Phinney Foundation Charity Ride and Dinner. Friday, November 19th at 9AM you can join Ben Serotta, Glen Hinshaw and Paraic McGlynn as they cruise the streets of Tucson with a fleet of Serotta demo bikes at their disposal. The ride will also be the first ever official Arizona Serotta rally. Of course all bike brands and rider abilities are welcome. Later that evening, you can join Ben Serotta and guests at a pre-race spaghetti dinner hosted at the Sheraton Tucson Hotel and Suites. The festivities will kick off at 8PM, and will continue until our droopy eyelids tell us that it is time to turn-in.

Cost for these two events has been kept low so that everyone can participate. A $10 recommended donation is all that it takes to participate in the ride, and the dinner will cost $40. Additional donations will be accepted at the dinner as well. The Sheraton is located at 5151 E Grant Road in Tucson, Arizona.

Davis Phinney is the winningest bicycle racer that America has ever had. The Olympics, World Championships, and Tour De France have all been Davis’ playground in the past. Davis developed his cycling prowess throughout his almost 20 year racing career, during which he achieved over 300 victories, including two stage wins in the Tour de France. Along with Lance Armstrong and Greg LeMond, Davis is one of only three Americans to win multiple stages of the Tour de France, the world’s most prestigious bike race.

In 2000, after exhaustive medical testing, Davis Phinney was diagnosed with early onset Parkinson’s disease. The Davis Phinney Foundation is dedicated to supporting research aimed at understanding, preventing and treating Parkinson’s disease and to improving the lives of people challenged by the disease. The Foundation is focusing its efforts on raising funds that will be distributed in the form of grants to laboratory researchers who are investigating the underlying causes of Parkinson’s disease and to clinical researchers who are striving to develop new therapies for Parkinson’s patients.